Israeli company uses AI to detect breast cancer, gets EU authorization
Israeli technology employing artificial intelligence to detect breast cancer has obtained European Union approval, Ibex Medical Analytics announced Wednesday.
Tel Aviv-based Ibex was established in 2016 and is focused on developing AI solutions to cancer diagnosis.
